News Conference News ACC 2017 Leaflet Thrombosis Common After Aortic Valve Implant, More So in TAVR Than in Surgery Michael O'Riordan March 19, 2017
News Conference News ACC 2017 Replacing Aspirin With Low-Dose Rivaroxaban for Post-ACS Therapy Appears Safe Todd Neale March 18, 2017
News Daily News The Long and Short of It: DAPT Duration Choice After Stenting Gets Help From New Score Todd Neale March 10, 2017
Presentation SIF 2017 Debate: With Modern Generation DES, 3 – 6 months of DAPT Is All You Need Presenter: William B. Bachinsky March 10, 2017
Presentation SIF 2017 PCI Pharmacology in 2017: Understanding the Essentials Presenter: MIchael A. Kutcher March 09, 2017
Presentation CRT 2017 Triple Antithrombotic Therapy in Patients with Atrial Fibrillation Undergoing Transcatheter Aortic Valve Replacement Presenter: Chadi Alraies February 22, 2017
News Conference News CRT 2017 Absorb BVS: Better Technique, Better Outcomes? More Data—and More Debate Michael O'Riordan February 21, 2017
News Conference News CRT 2017 Higher Mortality Among TAVR Patients With Atrial Fibrillation Treated With Triple Therapy Michael O'Riordan February 20, 2017
News Daily News ‘Misalignment’ Exists Between What Concerns Patients and Physicians Most After PCI Michael O'Riordan February 13, 2017
News Daily News Cobra Stent With Ultrathin Polymer Safe, Effective but Needs Testing in Tougher Patients Michael O'Riordan February 03, 2017
News Daily News Absorb BVS Meets Performance Goal in Diabetic Patients, but Is It Enough to Justify a Broader Label? Yael L. Maxwell December 23, 2016
News Daily News Noncardiac Surgery May Be Safe Earlier After PCI Than Previously Thought L.A. McKeown December 12, 2016
News Daily News Benefits of PCI for STEMI Not Attenuated in Patients With a Cancer History L.A. McKeown December 01, 2016
News Conference News AHA 2016 Rivaroxaban-Based Double or Triple Therapy Cuts Bleeding in Patients With A-fib Undergoing PCI: PIONEER AF-PCI Todd Neale November 14, 2016
Presentation Cardiovascular Interventions 2016 DAPT after Stenting: How Short When Needed and How Long When Tolerated? Presenter: Dean J. Kereiakes November 10, 2016
Presentation TCT 2016 FDA Perspectives on Short DAPT IDE Trials Presenter: Michael C. John, Gregg W. Stone, Andrew Farb November 01, 2016
Presentation TCT 2016 What Is Known (and What Is Not) About Discontinuing Aspirin or Clopidogrel in Patients on Chronic Oral Anticoagulants Plus DAPT Presenter: David P. Faxon, C. Michael Gibson, Freek W.A. Verheugt November 01, 2016
Presentation TCT 2016 The Big Picture: Incremental Bleeding Risks in Patients Requiring Chronic Oral Anticoagulants Plus DAPT Presenter: David P. Faxon, C. Michael Gibson, Christopher B. Granger November 01, 2016